Puma Biotechnology Raises FY2025 Sales Guidance from $212.000M-$222.000M to $220.000M-$223.000M vs $216.500M Est
Benzinga Newsdesk 12 months ago
NewsGuidance
Puma Biotechnology (NASDAQ:PBYI) raises FY2025 sales outlook from $212.000 million-$222.000 million to $220.000 million-$223.000 million vs $216.500 million estimate.
Puma Biotechnology (NASDAQ:PBYI) raises FY2025 sales outlook from $212.000 million-$222.000 million to $220.000 million-$223.000 million vs $216.500 million estimate.